Greg Pyszczymuka
Chief Commercial Officer · AYTU BIOPHARMA, INC
Individual
- 2024
- Jul 30, 2026
- 5
Other insiders active in the same sector
No other insider has filed at Greg Pyszczymuka's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Greg Pyszczymuka?
Greg Pyszczymuka is a corporate insider, tracked as Chief Commercial Officer of AYTU BIOPHARMA, INC (AYTU). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Greg Pyszczymuka submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
